Despite rheumatologists aiming to discontinue glucocorticoids by 24 months in giant cell arteritis, three quarters of patients continue to receive steroids at 48 months or longer.
Medscape Medical News
Source link
Despite rheumatologists aiming to discontinue glucocorticoids by 24 months in giant cell arteritis, three quarters of patients continue to receive steroids at 48 months or longer.
Medscape Medical News
Source link